Canine Papillomavirus (CPV) is a prevalent viral infection in dogs, characterized by the formation of benign warts or papillomas on the skin and mucous membranes.
University of Florida triple Gator and UF College of Veterinary Medicine alumna Cassandra Fleming, M.S., D.V.M., was recognized as one of this year’s 2026 UF Alumni Association 40 Gators Under 40,...
The field of animal healthcare is in a constant state of evolution, with the veterinary industry experiencing significant transformations due to the introduction of novel technologies and innovative...
The Miami-based diagnostics company launches publicly with exclusive partnerships with Kennel Connection and Pawp, bringing clinical-grade pet health intelligence to a rapidly growing industry.
The use of antimicrobial agents as growth promoters is widely established in modern commercial units, in order to improve and increase the animal production.
Two molecular clones of feline immunodeficiency virus were compared. The first clone, 34TF10, was from a Petaluma, Calif., isolate; the second, PPR, was isolated from a cat in the San Diego, Calif.,...
Canine babesiosis is a common tick transmitted disease of dogs worldwide. A number of Babesia sp. can infect dogs and the spectrum is increasing as molecular methods are developed to differentiate...
The University of Pennsylvania School of Veterinary Medicine (Penn Vet) has announced two interim leadership appointments to lead its academic and clinical programs.
Parnell Technologies Pty. Ltd. announced the U.S. launch of nixiFLOR® (florfenicol and flunixin meglumine) injectable solution, recently approved by the U.S. Food and Drug Administration for the...
Infection of domestic cats with the feline immunodeficiency virus (FIV) represents an important veterinary health problem and a useful animal model for the development of vaccines against acquired...
To determine the distribution of force between the articular surfaces of the humerus and radius and between the humerus and ulna in normal canine forelimbs.
Cornell scientists have taken a major step toward developing a safe, reversible, long-acting and 100% effective nonhormonal male contraceptive, considered the holy grail of male contraception.